XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jan. 31, 2024
Apr. 30, 2023
Current assets:    
Cash and cash equivalents $ 4,720 $ 6,883
Short term investments 4,377 27,790
Restricted cash, short-term 154 65
Accounts receivable 625 745
Contract assets 281 152
Inventory 3,460 1,044
Other current assets 3,927 994
Total current assets 17,544 37,673
Property and equipment, net 2,217 1,280
Intangibles, net 3,656 3,978
Right-of-use assets, net 2,610 1,751
Restricted cash, long-term 155
Goodwill 8,537 8,537
Total assets 34,564 53,374
Current liabilities:    
Accounts payable 1,466 952
Earnout payable 1,500
Accrued expenses 2,991 2,346
Contingent liabilities 1,085 1,202
Right-of-use liabilities, current portion 625 529
Contract liabilities 868 1,378
Total current liabilities 7,035 7,907
Deferred tax liability 203 203
Right-of-use liabilities, less current portion 2,065 1,311
Total liabilities 9,303 9,421
Commitments and contingencies (Note 14)
Shareholders’ Equity:    
Preferred stock, $0.001 par value; authorized 5,000,000 shares, none issued or outstanding; 100,000 designated as Series A
Common stock, $0.001 par value; authorized 100,000,000 shares, issued 59,551,090 shares and 56,304,642 shares, respectively; outstanding 59,463,073 shares and 56,263,728 shares, respectively 59 56
Treasury stock, at cost; 88,017 shares and 40,914 shares, respectively (368) (355)
Additional paid-in capital 326,472 324,393
Accumulated deficit (300,857) (280,096)
Accumulated other comprehensive loss (45) (45)
Total shareholders’ equity 25,261 43,953
Total liabilities and shareholders’ equity $ 34,564 $ 53,374